Patent Assignment
Reel/Frame 047580/0882
Assignment of Assignor's Interest
Recorded: 2018-11-26
Pages: 5
Assignor
TARSA THERAPEUTICS, INC.
Executed: 2018-11-20
Assignee
TAURUS DEVELOPMENT COMPANY LLC
505 COAST BLVD. SO., SUITE 102, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Room Temperature Stable Oral Calcitonin Formulation
Application:
62/371,377 →
PCT:
PCT/US2017/045229 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 13, 2017
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 043000/0757 →
Assignment of Assignor's Interest
Jul 13, 2017
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 043000/0768 →
Assignment of Assignor's Interest
Nov 26, 2018
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC
Reel/Frame 047580/0823 →
Assignment of Assignor's Interest
Nov 26, 2018
From: DAGGS, THOMAS A.; SHIELDS, PAUL A.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 047580/0869 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →